Gsk Plc ADR (GSK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2002 | 12-2001 | 09-2001 | 06-2001 | 03-2001 | |
| Sales | 7,307,000 | 8,087,000 | 7,191,000 | 7,328,000 | 6,898,000 |
| Gross Profit | 7,307,000 | 8,087,000 | 7,191,000 | 7,328,000 | 6,898,000 |
| Operating Income | 7,307,000 | 8,087,000 | 7,191,000 | 7,328,000 | 6,898,000 |
| Pre-tax Income | 7,307,000 | 8,087,000 | 7,191,000 | 7,328,000 | 6,898,000 |
| Net Income Continuous | 1,622,000 | 1,405,000 | 539,000 | 1,463,000 | 998,000 |
| Net Income | $1,622,000 | $1,405,000 | $539,000 | $1,463,000 | $998,000 |
| EPS Basic Total Ops | 0.68 | 0.58 | 0.23 | 0.60 | 0.41 |
| EPS Basic Continuous Ops | 0.68 | 0.58 | 0.22 | 0.60 | 0.41 |
| EPS Diluted Total Ops | 0.68 | 0.58 | 0.23 | 0.60 | 0.41 |
| EPS Diluted Continuous Ops | 0.68 | 0.58 | 0.22 | 0.60 | 0.41 |
| EBITDA(a) | $7,307,000 | $8,087,000 | $7,191,000 | $7,328,000 | $6,898,000 |